Month Flat Week Day
Date: Tuesday, June 27, 2023 7:00 pm - 8:30 pm
Categories: CME*

June 27, 2023

7:00 pm - 8:00 pm

Learning Objectives:

  • Assess the efficacy, safety, and mechanism of action of non-statin agents approved to manage LDL-C levels
  • Devise individualized evidence-based primary prevention plans for patients with elevated LDL-C levels
  • Develop personalized strategies for secondary prevention for patients with elevated LDL-C levels using evidence-based guidelines
  • Escalate treatment of elevated LDL-C levels by incorporating approved non-statin agents when statins alone do not achieve 2018 blood cholesterol guideline goals


Attendance is free, but registration is required. Register Today!

CME Accreditation

The AAFP has reviewed Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention, and deemed it acceptable for AAFP credit. Term of approval is from 04/04/2023 to 08/01/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit or the evaluation, please email This email address is being protected from spambots. You need JavaScript enabled to view it..


Member Login